Daniel Arias
Stock Analyst at Stifel
(5.00)
# 4
Out of 4,814 analysts
148
Total ratings
52.87%
Success rate
148.93%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Upgrades: Buy | $260 | $190.66 | +36.37% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.63 | +242.21% | 2 | Mar 12, 2025 | |
| GH Guardant Health | Maintains: Buy | $45 → $53 | $45.18 | +17.31% | 2 | Feb 21, 2025 | |
| BRKR Bruker | Maintains: Hold | $70 → $57 | $37.74 | +51.03% | 6 | Feb 14, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $7.51 | +139.68% | 6 | Feb 13, 2025 | |
| AVTR Avantor | Maintains: Buy | $28 → $26 | $15.40 | +68.83% | 8 | Feb 10, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $4.73 | +26.98% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,014.38 | +42.94% | 7 | Nov 11, 2024 | |
| TEM Tempus AI | Downgrades: Hold | $45 → $65 | $40.45 | +60.69% | 2 | Nov 11, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $67 | $41.59 | +61.12% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $321.12 | +12.11% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $680 → $665 | $436.79 | +52.25% | 15 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $102.47 | +47.36% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $40.72 | +13.83% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $1.78 | +463.38% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $130.05 | +59.17% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $95.54 | +15.14% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $65 | $51.07 | +27.28% | 10 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $71.16 | +181.06% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.12 | +135.85% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $3.10 | +222.58% | 2 | May 31, 2022 |
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $190.66
Upside: +36.37%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.63
Upside: +242.21%
Guardant Health
Feb 21, 2025
Maintains: Buy
Price Target: $45 → $53
Current: $45.18
Upside: +17.31%
Bruker
Feb 14, 2025
Maintains: Hold
Price Target: $70 → $57
Current: $37.74
Upside: +51.03%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $7.51
Upside: +139.68%
Avantor
Feb 10, 2025
Maintains: Buy
Price Target: $28 → $26
Current: $15.40
Upside: +68.83%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $4.73
Upside: +26.98%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,014.38
Upside: +42.94%
Tempus AI
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $40.45
Upside: +60.69%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $41.59
Upside: +61.12%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $321.12
Upside: +12.11%
Oct 24, 2024
Maintains: Buy
Price Target: $680 → $665
Current: $436.79
Upside: +52.25%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $102.47
Upside: +47.36%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $40.72
Upside: +13.83%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $1.78
Upside: +463.38%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $130.05
Upside: +59.17%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $95.54
Upside: +15.14%
Feb 2, 2024
Downgrades: Hold
Price Target: $65
Current: $51.07
Upside: +27.28%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $71.16
Upside: +181.06%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.12
Upside: +135.85%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $3.10
Upside: +222.58%